Lisa Gill
Stock Analyst at JP Morgan
(3.03)
# 2,523
Out of 5,182 analysts
142
Total ratings
45.19%
Success rate
0.32%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintains: Overweight | $397 → $411 | $365.49 | +12.45% | 8 | Apr 28, 2026 | |
| TDOC Teladoc Health | Maintains: Neutral | $9 → $7 | $6.00 | +16.67% | 10 | Mar 13, 2026 | |
| MDLN Medline | Maintains: Overweight | $50 → $53 | $44.75 | +18.45% | 2 | Mar 10, 2026 | |
| GDRX GoodRx Holdings | Downgrades: Neutral | n/a | $2.35 | - | 3 | Feb 27, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $260.33 | +26.76% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $205.82 | +18.06% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $312.25 | +34.19% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $837.55 | +32.17% | 15 | Feb 10, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $367.20 | +5.94% | 11 | Feb 2, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $81.14 | +24.48% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $23 | $21.78 | +5.60% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $24.55 | +34.42% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $18.59 | +39.86% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $286.04 | +31.10% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $6.63 | +50.94% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $194.81 | -2.47% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $22.56 | +32.98% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $27.81 | +47.43% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $232.84 | +9.95% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $33.24 | -45.85% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $8.13 | -38.50% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $14.43 | +94.04% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.77 | +84.24% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $189.03 | +108.96% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $167.00 | +11.38% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $178.65 | -21.63% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $431.58 | -23.07% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $425 → $225 | $28.50 | +689.47% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.64 | +4.78% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $76.09 | +9.08% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $49.81 | +96.75% | 1 | Jan 6, 2023 |
Elevance Health
Apr 28, 2026
Maintains: Overweight
Price Target: $397 → $411
Current: $365.49
Upside: +12.45%
Teladoc Health
Mar 13, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $6.00
Upside: +16.67%
Medline
Mar 10, 2026
Maintains: Overweight
Price Target: $50 → $53
Current: $44.75
Upside: +18.45%
GoodRx Holdings
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.35
Upside: -
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $260.33
Upside: +26.76%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $205.82
Upside: +18.06%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $312.25
Upside: +34.19%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $837.55
Upside: +32.17%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $367.20
Upside: +5.94%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $81.14
Upside: +24.48%
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $21.78
Upside: +5.60%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $24.55
Upside: +34.42%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $18.59
Upside: +39.86%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $286.04
Upside: +31.10%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $6.63
Upside: +50.94%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $194.81
Upside: -2.47%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $22.56
Upside: +32.98%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $27.81
Upside: +47.43%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $232.84
Upside: +9.95%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $33.24
Upside: -45.85%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $8.13
Upside: -38.50%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $14.43
Upside: +94.04%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.77
Upside: +84.24%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $189.03
Upside: +108.96%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $167.00
Upside: +11.38%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $178.65
Upside: -21.63%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $431.58
Upside: -23.07%
Jan 5, 2024
Downgrades: Neutral
Price Target: $425 → $225
Current: $28.50
Upside: +689.47%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.64
Upside: +4.78%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $76.09
Upside: +9.08%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $49.81
Upside: +96.75%